Jump to content

Digitalizing Biopharma: R&D Innovation through Operational Excellence

Presented at BIO-IT Boston, Virtual Meeting
Sebastian Schlicker, Head, Operations - Biologics Business, Genedata

We present a purpose-built E2E workflow platform that supports, both operationally and scientifically, the entire biopharma R&D process. The platform increases overall process efficiency and quality by integrating and automating workflows and identifying the most promising drug candidates to move forward. We show how the platform enables the exploration of new R&D processes, such as the engineering of highly-engineered multi-specific antibodies and novel cell and gene therapies (CARTs, TCRs).


Request Resource

By submitting my data, I give consent to the collection, processing and use of my personal data in accordance with the Genedata privacy policy